A novel small mimetic molecule TLR4 antagonist (IAXO-102) modulates TLR4 proinflammatory signalling and inhibits aortic aneurysms development. Issue 1 (July 2015) - Huggins, C.L.; Pierce, S.; Neumann, F.; Peri, F.; Cockerill, G.W.; Pirianov, G.